期刊文献+

山慈姑体外抑菌活性的初步研究 被引量:3

Initial Study on the in vitro Antibacterial Activity of Pseudobulbus Cremastrae Seu Pleiones
下载PDF
导出
摘要 目的探讨山慈姑的体外抑菌活性。方法将山慈姑提取物经大孔树脂(D-101)分离得到4个组分A,B,C和D,用倍比稀释法测定其抑菌活性。结果金黄色葡萄球菌(Staphylococcus aureus)对组分D有很强的敏感性,MIC≤12.5mg/ml,对组分B有中等强度的敏感性,MIC为12.5~25mg/ml;白色念珠菌(Candida albicans,ATCC-10231)对组分B和组分D有中等强度的敏感性,MIC为12.5~25mg/ml,大肠杆菌(Escherichia coli)对各组分的敏感性都较低,MIC〉50mg/ml。结论山慈姑提取物B和D对金黄色葡萄球菌和白色念珠菌具有较强的抑菌效果。 Objective To study the in vitro growth inhibitory activity ofpseudobulbus cremastrae seu pleiones on bacteria. Methods The extract from pseudobulbus cremastrae seu pleione was separated by the way of resin column chromatography ( D - 101 ) to obtain four constituents A, B, C and D, and their antibacterial activities in vitro were determined by double dilution. Results Staphylococcus aureus showed a high sensitivity to constituent D( MIC ≤ 12.5 mg/ml), and a medium sensitivity to constituent B( 12.5 mg/ml 〈 MIC ≤25 mg/ml) ; Candida albicans( ATCC -10231 )showed a medium sensitivity to constituent B and D( 12.5 mg/ml 〈 MIC ≤25mg/ml) ; Escherichia coli showed a low sensitivity to constituent A,B ,C and D( MIC 〉 50mg/ml). Conclusion The constituent B and D from pseudobulbus cremastrae seu pleione have good antibacterial activity against Staphylococcus aureus and Candida albicans.
出处 《时珍国医国药》 CAS CSCD 北大核心 2009年第3期594-595,共2页 Lishizhen Medicine and Materia Medica Research
基金 贵州省中药现代化专项资助项目(黔科合中药专字[2007]5021号) 北京大学天然药物及仿生药物国家重点实验室开发基金资助项目
关键词 山慈姑 体外抑菌 倍比稀释法 最低抑菌浓度 Pseudobulbus cremastrae seu pleiones Antibacterial effect in vitro Double dilution MIC
  • 相关文献

参考文献5

二级参考文献19

  • 1王丽,阿地里江.阿不都拉,孙华,阿不都拉.阿巴斯.松萝酸研究进展[J].生物技术通讯,2005,16(4):472-473. 被引量:20
  • 2曾春兰,钟振国.中药抗菌作用的研究进展[J].广西中医学院学报,2006,9(1):51-53. 被引量:38
  • 3National Committee for Clinical Latoratory Standards.Minutes US NCCLS antifungal susceptibility subcommittee meeting on interpretive breakpoints[S].NCCLS,2002.Villanova,PA. 被引量:1
  • 4National Committee for Clinical Latoratory Standards.Reference method for broth dilution antifugal susceptibility testing of yeasts[S].M-27A.NCCLS,1997.17:1-13. 被引量:1
  • 5陈奇.中药药理实验方法学[M].北京:人民卫生出版社,1993.393. 被引量:137
  • 6Kweon D H, Han N S, Park K M, et al. Overproduction of Phytolacca Insularis Protein in Batch and Fed-batch Culture of Recombinant Escherichia coli [J]. Process Biochem., 2001, 36(6): 537-542. 被引量:1
  • 7Woyski D, Jill R C V. Enhanced Expression of Cytochrome P450s from Lac-based Plasmids Using Lactose as the Inducer [J]. Arch.Biochem. Biophys., 2001, 388(2): 276-280. 被引量:1
  • 8Srivastava M, Nayak J, Mehrotra V, et al. High Level Expression in Escherichia coli and Purification of Immunoreactive Recombinant Bonnet Monkey Zone Pellucida Glycoprotein-3 [J]. Process Biochem.,1999, 35(5): 451-457. 被引量:1
  • 9萨姆布鲁克J 弗里奇EF 金冬雁 黎孟枫 曼尼阿蒂斯T.分子克隆实验指南 第二版[M].北京:科学出版社,1996.333-341. 被引量:1
  • 10Steven D D, Lisa M O'Sullivanb, Sejal P, et al. Large Scale Production of Cyclohexanone Monooxygenase from Escherichia coli TOP10 pQR239 [J]. Enzyme Microb. Technol., 2001, 28(2):265-274. 被引量:1

共引文献76

同被引文献20

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部